Namsik Chung

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Characterization and Quantification of Vortex Flow in the Human Left Ventricle by Contrast Echocardiography Using Vector Particle Image Velocimetry

Geu‐Ru Hong, Gianni Pedrizzetti, Giovanni Tonti et al. · JACC. Cardiovascular imaging · 2008 · 337 citations · Full text

Engineering, Health Sciences, Vortex Flows +12

Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-κB through Akt and p38 inhibition in RAW 264.7 macrophage cells

Ho Gyoung Kim, Bhushan Shrestha, So Yeon Lim et al. · European Journal of Pharmacology · 2006 · 292 citations · Full text

Inflammation, Anti-inflammatory, Molecular Physiology +14

Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification

Min‐Chan Park, Sang‐Won Lee, Park Yb et al. · Scandinavian Journal of Rheumatology · 2005 · 279 citations · Full text